Health Professionals

Welcome to the Health Professionals Page, where the Virginia Department of Health (VDH) will provide and maintain all available and up-to-date resources, including clinician's letters, information on infection prevention, testing, specialty care, and other topics relevant for health professionals and their response to COVID-19 in Virginia. Thank you for your continued work to protect the health and well-being of all Virginians.


Hot Topics


  • 11/30/2021 -FDA's Antimicrobial Drugs Advisory Committee will hold a meeting on November 30, 2021 to discuss the available data supporting the use of molnupiravir to treat mild to moderate COVID-19 in adults who have tested positive for COVID-19, and who are at high risk for progression to severe COVID-19, including hospitalization or death. Molnupiravir is an oral antiviral drug and is not authorized by the FDA at this time.

  • 11/19/2021 - FDA authorized and CDC recommended expanding the eligibility for a COVID-19 booster shot to everyone aged 18 years or older. A single booster dose is now recommended for any adult who completed a Pfizer-BioNTech or Moderna vaccine series at least six months ago. The earlier recommendation of a single booster dose for those adults who received a Johnson & Johnson/Janssen vaccine at least two months ago still applies. Additional information is available in VDH’s clinician letter and CDC’s clinical considerations.

  • 11/18/2021 - COCA webinar: What Clinicians, Pharmacists, and Public Health Partners Need to Know about Antibiotic Prescribing and COVID-19. CDC has published several studies characterizing antibiotic prescribing during the COVID-19 pandemic in outpatient, nursing home, and hospital settings. Findings from these studies and others inform opportunities to improve antibiotic use and guide the development of resources to support healthcare professionals and health systems. Case studies representing common clinical scenarios were discussed during the webinar to support decisions related to antibiotic prescribing. The recording of the webinar is now available.

  • 11/17/2021 - CDC issued Emergency Use Instructions (EUI) and updated its clinical considerations to allow the Pfizer-BioNTech COVID-19 vaccine to be given as an additional primary dose or booster dose to certain people who completed a vaccine primary series with certain COVID-19 vaccines that are not authorized or approved by FDA. This means that eligible people who were vaccinated outside of the U.S. with these vaccines, or who received certain non-FDA authorized or approved COVID-19 vaccines through a clinical trial, can get an additional primary dose or booster dose of Pfizer-BioNTech COVID-19 vaccine. EUI fact sheets for healthcare providers and recipients and caregivers are now available.

  • 11/12/2021 - Ellume is recalling their COVID-19 Home Test because these tests have the potential to give false positive SARS-CoV-2 test results. For these tests, a false positive test result shows that a person has the virus when they do not have it. The recall described in this notice is for the same issue that was previously announced in the October 5, 2021, FDA Safety Communication: Potential for False Positive Results with Certain Lots of Ellume COVID-19 Home Tests Due to a Manufacturing Issue. The FDA has identified this as a Class I recall, the most serious type of recall. Use of these tests may cause serious adverse health consequences or death.

  • 11/9/2021 - As a new phase of the COVID-19 vaccination campaign begins for children ages 5 to 11 years old, U.S. Surgeon General Dr. Vivek Murthy releases a Community Toolkit for Addressing Health Misinformation - PDF to help Americans navigate the serious threat of health misinformation, especially online. The Surgeon General’s Community Toolkit for Addressing Health Misinformation provides specific guidance to individuals, health care professionals and administrators, teachers, school administrators, librarians, and faith leaders to understand, identify, and stop the spread of health misinformation in their communities.

  • 11/2/2021 - CDC now recommends COVID-19 vaccines for children aged 5 through 11 years. The latest guidance and resources on COVID-19 vaccines are available at VDH’s COVID-19 vaccine web page for Healthcare Professionals.

  • 10/29/21 - CDC’s Science Brief: SARS-CoV-2 Infection-induced and Vaccine-induced Immunity summarizes current scientific evidence regarding infection-induced and vaccine-induced immunity, including more than 90 peer-reviewed and preprint publications, and unpublished CDC data. Based on the review, CDC continues to strongly recommend vaccinating previously infected individuals to provide a higher, more robust, and more consistent level of immunity than infection alone. 





VDH COVID-19 Point of Care (POC) Test Reporting Portal (9/15/20)

Virginia’s Confidential Morbidity Report Portal

CDC Information for ICD-10-CM Official Coding for COVID-19 (11/24/20)

VDH Guidance

 VDH Interim Covid-19 Antigen Testing Recommendations (11/3/21)

VDH Guidance for Assessing and Managing Exposed, Asymptomatic Healthcare Personnel (10/7/21)

VDH COVID-19 Testing Algorithm for Health Care Providers (8/27/21)

VDH is hosting Project ECHO COVID-19 Special Sessions for clinicians across Virginia. Information on registration, CME, and session topics can be found here.

Click here for a recorded demo of COVIDCheck, Virginia's online symptom checker and triage tool.

State Guidance

Resource Allocation under Crisis Standards of Care for COVID (12/2/20)

(FAQ)Communications for Impacted Providers (01/12/21)

Federal Guidance

CDC Information for Healthcare Professionals

Page Last Updated: November 23, 2021